Ionis Pharmaceuticals Raises FY2026 Sales Guidance from $800.000M-$825.000M to $875.000M-$900.000M vs $815.735M Est

Benzinga Newsdesk www.benzinga.com Positive 94.4%

Neg 0% Neu 0% Pos 94.4%

Ionis Pharmaceuticals (NASDAQ:IONS) raises FY2026 sales outlook from $800.000 million-$825.000 million to $875.000 million-$900.000 million vs $815.735 million estimate.